Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Business
  • Education
  • Real Estate
Washingtoner

If you purchased certain microcap stock between May 2016 and July 2019, you may be eligible for distribution from the O'Rourke Distribution Fund
Washingtoner/10125238

Trending...
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • City of Spokane and City Council Announce 2027 Legislative Priorities
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
SEATTLE, July 23, 2021 /PRNewswire/ -- On July 17, 2019, the United States Securities and Exchange Commission (the "SEC") filed a lawsuit against Garrett O'Rourke and Michael J. Black alleging that, between May 2016 and July 2019, the defendants schemed to sell the stock of the five publicly traded companies listed below to investors through false and misleading statements and high pressure stock promotional campaigns, SEC v. O'Rourke, et al., 19-CV-4137 (KAM) (E.D.N.Y.).  The SEC also alleged that the defendants disguised their control over some or all of the companies and their stock, thereby circumventing their obligations to register the stock with the Commission pursuant to Section 5 of the Securities Act of 1933 and conduct sales in accordance with the governing registration regulations.  The matter has been resolved against O'Rourke, and the SEC has collected over $5.7 million (the "O'Rourke Distribution Fund") that it now seeks to distribute.  Additional funds timely directed to the O'Rourke Distribution Fund, and accrued interest, will be added to the Distribution Fund.

Company (Trading Symbol) [Relevant Period start and end dates (inclusive)]:
  • AV1 Group, Inc. (AVOP) [5/4/2016 through 10/19/2016];
  • EnviroTechnologies International, Inc. (ETII) [2/1/2017 through 6/30/2017];
  • EnviroTechnologies International, Inc. (ETII) [1/30/2018 through 5/10/2018];
  • Cyberfort Software, Inc. (CYBF) [6/29/2018 through 8/15/2018];
  • Link Reservations, Inc. (LRSV) [10/7/2016 through 2/9/2017]; and
  • BioHemp International, Inc. (BKIT) [5/10/2019 through 7/16/2019].

On March 4, 2021, the United States District Court for the Eastern District of New York appointed Miller Kaplan Arase LLP as Tax Administrator and appointed JND Legal Administration as Distribution Agent (the "Distribution Agent").  On May 26, 2021, the Court approved a plan for the distribution of the O'Rourke Distribution Fund (the "Plan").  The Plan is  publicly available at www.OrourkeDistributionFund.com, as well as on the SEC's webpage for this matter  (https://www.sec.gov/divisions/enforce/claims/orourke-black.htm).

More on Washingtoner
  • Tacoma: Planning Commission to Hold Public Hearing on December 16 Regarding Proposed Tree and Landscape Code Update
  • Enjoy the 2026 holidays with Spokane Parks & Recreation
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
  • Auction Finder USA Surpasses 120,000 Live Auction Listings Across All 50 States
  • PinnacleQM launches new enterprise website to help Australian organisations deliver more with confidence

If you purchased one or more of the securities set forth above during the corresponding Relevant Period(s) and would like to be considered for eligibility  for a distribution from the O'Rourke Distribution Fund, you must submit a completed and signed Proof of Claim Form ("Claim Form"), including adequate supporting documentation of your purchases and a completed tax certification, to the Distribution Agent by the Claims Bar Date.

The Claim Form is available at www.OrourkeDistributionFund.com.  You may submit your Claim Form online no later than 11:59 pm PT on November 9, 2021 following the directions at https://secure.orourkedistributionfund.com.  Alternatively, you may send your Claim Form to the Distribution Agent; Claim Forms must be postmarked no later than November 9, 2021 if sent by First Class Mail; and if not by First Class Mail, received by the Distribution Agent by November 9, 2021. If not submitted online, Claim Forms should be directed to the following address:

O'Rourke Distribution Fund
c/o JND Legal Administration
PO Box 91401

More on Washingtoner
  • Tacoma: Statement from District 4 Council Member Sandesh Sadalge and At-Large Council Member Olgy Diaz on Sale of Northwest ICE Processing Center to Federal Government
  • Loud! OOH Launches UK's First Free Planning Tool for UK Outdoor Advertising Budgets
  • Tacoma Creates 2025-2026 Annual Report Demonstrates Continued Investment in Arts, Culture, Heritage, and Science Across Tacoma
  • Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
  • Not a Black Box Launches TalentOS, the First Talent Harness Operating System

Seattle, WA 98111

Brokers, Dealers and other nominees that may have records of purchasers of the Securities during the Relevant Period must notify the respective beneficial owners within fourteen (14) days of receipt of the Claims Packet so that beneficial owners may timely file a claim or provide to the Distribution Agent within fourteen (14) days of receipt a list of last known names and addresses for all beneficial owners for whom the record holders purchased the Securities during the Relevant Period.

Additional information regarding the O'Rourke Distribution Fund, including the Distribution Plan, the Notice, the Claim Form, relevant deadlines, and related materials are available on the Distribution website at www.OrourkeDistributionFund.com.  You may obtain additional information or request copies of the Claim Form by contacting the Distribution Agent toll-free at (833) 358-1844, emailing [email protected], or writing to:

O'Rourke Distribution Fund
c/o JND Legal Administration
PO Box 91401
Seattle, WA 98111

Please check the website www.OrourkeDistributionFund.com frequently for updates.

SOURCE JND Legal Administration
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • The Great Junk Hunt Returns to Puyallup: The Ultimate Holiday Vintage Market is Back!
  • Green Revolution CBD Spotlights Its Water-Soluble Focus Tincture With CBD, CBG and Lion's Mane
  • Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
  • Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
  • Coming Up on CNBC: Bilha Wachira Champions Financial Protection During Long-Term Care Awareness Month
  • Tacoma: Closures Projected to Allow for Arterial Work
  • Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • Stamp Me Launches Web App Ahead of 15th Anniversary
  • The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities
  • LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Tacoma: Council Member Sandesh Sadalge Focuses Today's District 4 Town Hall on the City's Biennial Budget
  • City of Tacoma Awarded $2.25 Million in Federal Highway Safety Improvement Program Grant Funding for South 21st Street Corridor
  • New Self-Service Sandbag Station at Tacoma Recovery and Transfer Center
  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 329
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 295
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 182
  • One in three Americans may have lost track of retirement savings from a previous job - 119
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026 - 116
  • Tacoma: OMWBE Active Certification Class on November 16 - 102
  • Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network
  • ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search
  • Paraguay Expedition Offers a Different View of Human Resilience
  • Sturtevant's Offers Free Ski and Snowboard Edge-and-Wax Services in Bellevue Oct. 29

Similar on Washingtoner

  • Scott Glickson Joins STS Capital Partners as Managing Director
  • BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
  • Loud! OOH Launches UK's First Free Planning Tool for UK Outdoor Advertising Budgets
  • Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
  • Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
  • Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
  • Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute